United Therapeutics Corporation et al v. ANI Pharmaceuticals, Inc.
| Supernus Pharmaceuticals, Inc. and United Therapeutics Corporation |
| ANI Pharmaceuticals, Inc. |
| 1:2021cv00489 |
| April 1, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 28, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for ANI Pharmaceuticals, Inc. filed by ANI Pharmaceuticals, Inc.. (Keller, Karen) |
| Filing 9 ANSWER to #1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against Supernus Pharmaceuticals, Inc., United Therapeutics Corporation, by ANI Pharmaceuticals, Inc..(Keller, Karen) Modified on 5/28/2021 (nms). |
SO ORDERED, re #8 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: ANI Pharmaceuticals, Inc. answer due 6/26/2021). Signed by Judge Richard G. Andrews on 4/26/2021. (nms)
|
| Filing 8 STIPULATION TO EXTEND TIME for defendant to respond to the Complaint to June 25, 2021 - filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (Flynn, Michael) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 SUMMONS Returned Executed by United Therapeutics Corporation, Supernus Pharmaceuticals, Inc.. ANI Pharmaceuticals, Inc. served on 4/5/2021, answer due 4/26/2021. (Blumenfeld, Jack) |
| Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate The Vanguard Group, Inc., Other Affiliate BlackRock Institutional Trust Company for Supernus Pharmaceuticals, Inc.; Other Affiliate BlackRock Inc. for United Therapeutics Corporation filed by Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 23, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/23/2023. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT filed against ANI Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3584393.) - filed by United Therapeutics Corporation, Supernus Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-L, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
